| Product Code: ETC12820591 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel AI Drug Discovery Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel AI Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Israel AI Drug Discovery Market - Industry Life Cycle |
3.4 Israel AI Drug Discovery Market - Porter's Five Forces |
3.5 Israel AI Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Israel AI Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel AI Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.8 Israel AI Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel AI Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions |
4.2.2 Technological advancements in artificial intelligence |
4.2.3 Rising investments in AI-driven healthcare research |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the healthcare industry |
4.3.2 High costs associated with AI implementation in drug discovery |
5 Israel AI Drug Discovery Market Trends |
6 Israel AI Drug Discovery Market, By Types |
6.1 Israel AI Drug Discovery Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Israel AI Drug Discovery Market Revenues & Volume, By Component, 2021 - 2031F |
6.1.3 Israel AI Drug Discovery Market Revenues & Volume, By Software, 2021 - 2031F |
6.1.4 Israel AI Drug Discovery Market Revenues & Volume, By Services, 2021 - 2031F |
6.2 Israel AI Drug Discovery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel AI Drug Discovery Market Revenues & Volume, By Target Identification, 2021 - 2031F |
6.2.3 Israel AI Drug Discovery Market Revenues & Volume, By Drug Screening, 2021 - 2031F |
6.2.4 Israel AI Drug Discovery Market Revenues & Volume, By Lead Optimization, 2021 - 2031F |
6.2.5 Israel AI Drug Discovery Market Revenues & Volume, By Preclinical Testing, 2021 - 2031F |
6.3 Israel AI Drug Discovery Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 Israel AI Drug Discovery Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Israel AI Drug Discovery Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.4 Israel AI Drug Discovery Market Revenues & Volume, By Immunology, 2021 - 2031F |
6.3.5 Israel AI Drug Discovery Market Revenues & Volume, By Cardiovascular, 2021 - 2031F |
6.4 Israel AI Drug Discovery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel AI Drug Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Israel AI Drug Discovery Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
6.4.4 Israel AI Drug Discovery Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.5 Israel AI Drug Discovery Market Revenues & Volume, By Contract Research Organizations, 2021 - 2031F |
7 Israel AI Drug Discovery Market Import-Export Trade Statistics |
7.1 Israel AI Drug Discovery Market Export to Major Countries |
7.2 Israel AI Drug Discovery Market Imports from Major Countries |
8 Israel AI Drug Discovery Market Key Performance Indicators |
8.1 Number of AI drug discovery patents filed |
8.2 Percentage increase in research collaborations between AI companies and pharmaceutical firms |
8.3 Number of successful drug discoveries attributed to AI technologies |
8.4 Increase in funding for AI drug discovery projects |
8.5 Adoption rate of AI tools and platforms in drug discovery research |
9 Israel AI Drug Discovery Market - Opportunity Assessment |
9.1 Israel AI Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Israel AI Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel AI Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.4 Israel AI Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel AI Drug Discovery Market - Competitive Landscape |
10.1 Israel AI Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Israel AI Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here